NO973279L - PIK-related kinase materials and cell cycle checkpoint methods - Google Patents

PIK-related kinase materials and cell cycle checkpoint methods

Info

Publication number
NO973279L
NO973279L NO973279A NO973279A NO973279L NO 973279 L NO973279 L NO 973279L NO 973279 A NO973279 A NO 973279A NO 973279 A NO973279 A NO 973279A NO 973279 L NO973279 L NO 973279L
Authority
NO
Norway
Prior art keywords
pik
cell cycle
cycle checkpoint
mccs1
kinase
Prior art date
Application number
NO973279A
Other languages
Norwegian (no)
Other versions
NO973279D0 (en
Inventor
Merl F Hoekstra
Doug A Holtzman
Kathleen S Keegan
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Publication of NO973279D0 publication Critical patent/NO973279D0/en
Publication of NO973279L publication Critical patent/NO973279L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Gener som koder for cellesyklus- kontrollpunkt-fosfatidyllnositolkinase (PIK)-beslektede proteiner som er vesentlige for DNA-skaderesponser i celler. Disse PIK-beslektede kinaser er nødvendige i regulatoriske reaksjons- veier som stanser cellesyklusen etter DNA-skade, for å tillate DNA-reparasjon før mitose eller initiering av DNA- replikasjon. En ny human cellesyklus- kontrollpunkt-PIK-beslektet kinase, MCCSl, og polynukleotidsekvenser som koder for MCCSl er nærmere beskrevet. Analyser for identifikasjon av modulatorer av MCCSl anvendelige som f.eks. kjemoterapi- og strålings- adjuvanser, er også beskrevet. Analyser for Identifikasjon av modulatorer av det cellesykluskontrollpunkt-fosfat- idylinositolkinase (PIK)-besLektede protein, identifisert som ATM, er også beskrevet.Genes encoding cell cycle checkpoint phosphatidyl nilositol kinase (PIK) -related proteins that are essential for DNA damage responses in cells. These PIK-related kinases are required in regulatory pathways that stop the cell cycle after DNA damage, to allow DNA repair before mitosis or initiation of DNA replication. A new human cell cycle checkpoint PIK-related kinase, MCCS1, and polynucleotide sequences encoding MCCS1 are described in more detail. Assays for identification of modulators of MCCS1 useful as e.g. chemotherapy and radiation adjuvants are also described. Assays for the identification of modulators of the cell cycle checkpoint phosphate-idylinositol kinase (PIK) -related protein, identified as ATM, are also described.

NO973279A 1995-11-16 1997-07-15 PIK-related kinase materials and cell cycle checkpoint methods NO973279L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55866695A 1995-11-16 1995-11-16
US73129696A 1996-02-27 1996-02-27
US72530496A 1996-10-21 1996-10-21
PCT/US1996/019337 WO1997018323A2 (en) 1995-11-16 1996-11-18 Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity

Publications (2)

Publication Number Publication Date
NO973279D0 NO973279D0 (en) 1997-07-15
NO973279L true NO973279L (en) 1997-09-16

Family

ID=27415779

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973279A NO973279L (en) 1995-11-16 1997-07-15 PIK-related kinase materials and cell cycle checkpoint methods

Country Status (6)

Country Link
CN (1) CN1199420A (en)
AU (1) AU1461197A (en)
IL (1) IL121306A0 (en)
NO (1) NO973279L (en)
PL (1) PL322876A1 (en)
WO (1) WO1997018323A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5777093A (en) * 1995-05-16 1998-07-07 Ramot-University Authority For Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
US5858661A (en) * 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
GB9518220D0 (en) * 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
AU8400398A (en) * 1997-07-11 1999-02-08 Trustees Of The University Of Pennsylvania, The Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use
GB9714971D0 (en) * 1997-07-16 1997-09-24 Cancer Res Campaign Tech Assays,therapeutic methods and means
GB9718952D0 (en) * 1997-09-05 1997-11-12 Medical Res Council Mammalian chk1 effector cell cycle checkpoint protein kinase materials and methods
CA2216559A1 (en) * 1997-09-25 1999-03-25 Michel Roberge G2 checkpoint inhibitors and assay
GB9722320D0 (en) * 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins
US6071691A (en) * 1998-04-27 2000-06-06 Oregon Health Science University Materials and methods for modulating differentiation
US6348311B1 (en) 1999-02-10 2002-02-19 St. Jude Childre's Research Hospital ATM kinase modulation for screening and therapies
US6387640B1 (en) 1999-02-10 2002-05-14 St. Jude Children's Research Hospital ATM kinase modulation for screening and therapies
US6670167B1 (en) 1999-11-01 2003-12-30 Agouron Pharmaceuticals, Inc. Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
WO2004038008A2 (en) * 2002-10-25 2004-05-06 University Of Massachusetts Modulation of cellular proliferation
US7429660B2 (en) 2003-08-13 2008-09-30 Kudos Pharmaceuticals Limited ATM inhibitors
US20070238731A1 (en) 2004-09-20 2007-10-11 Kudos Pharmaceuticals Limited Dna-Pk Inhibitors
TW200638938A (en) 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR053358A1 (en) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd DNA INHIBITORS - PK

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518220D0 (en) * 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene

Also Published As

Publication number Publication date
WO1997018323A3 (en) 1997-10-09
NO973279D0 (en) 1997-07-15
WO1997018323A2 (en) 1997-05-22
CN1199420A (en) 1998-11-18
AU1461197A (en) 1997-06-05
PL322876A1 (en) 1998-03-02
IL121306A0 (en) 1998-01-04

Similar Documents

Publication Publication Date Title
NO973279L (en) PIK-related kinase materials and cell cycle checkpoint methods
DE69715621D1 (en) THREE HYBRID SCREENING TEST
Walderhaug et al. Structural relatedness of three ion-transport adenosine triphosphatases around their active sites of phosphorylation.
McVey et al. Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication
NO984229L (en) Compounds and Methods for Immunotherapy and Immunodiagnosis of Prostate Cancer
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
DK21985A (en) MONOCLONAL ANTIBODIES AGAINST NON-TASTE LUNG CANCER
DE69229681D1 (en) A PROTEIN THAT RECOGNIZES SPECIFIC DNA STRUCTURES AND ITS USE
NO20051347L (en) eNOS mutants useful for gene therapy.
Boutté et al. Proteomic analysis and brain‐specific systems biology in a rodent model of penetrating ballistic‐like brain injury
NO962084L (en) DNA sequence encoding a BMP receptor
Juris et al. Identification of otubain 1 as a novel substrate for the Yersinia protein kinase using chemical genetics and mass spectrometry
NO20010362L (en) Nucleic acids encoding proteins involved in sensory transduction
NO331018B1 (en) In vitro method for the determination of pre-neoplastic and / or neoplastic conditions in mammals by purinergic receptor expression, and the use and kit for such screening.
Sluder et al. Nuclear envelope breakdown is under nuclear not cytoplasmic control in sea urchin zygotes.
ATE173295T1 (en) ECDYSTEROID-DEPENDENT GENE REGULATION IN MAMMAL CELLS
Liebke Multiple SecA protein isoforms in Escherichia coli
MX9705466A (en) Cell cycle checkpoint pik-related kinase materials and methods.
Jenkins et al. In vitro translation of oogenetic messenger RNA of sea urchin eggs and picornavirus RNA with a cell-free system from sarcoma 180
WO1999020761A3 (en) Compositions and methods for identifying and testing therapeutics against hsv infection
Kamada et al. Proteomic analysis of bone marrow‐adherent cells in rheumatoid arthritis and osteoarthritis
Holtlund et al. A Comparison of Purified Poly (ADP‐ribose) Polymerases from Ehrlich Ascites Tumor Cells, Pig Thymus, and HeLa S3 Cells
Kito et al. Discrimination between stable and dynamic components of protein complexes by means of quantitative proteomics
Wang et al. Location of the C-terminus of titin at the Z-line region in the sarcomere
BR9708256A (en) Process for identifying genes with specific expression to the site or preferred site in specific labeling cells present in a cell environment different or not from that of its origin and use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application